An inducible nitric oxide synthase-luciferase reporter system for in vivo testing of anti-inflammatory compounds in transgenic mice

Journal of Immunology

Volumn 170, Issue 12, 2003, Pages 6307-6319

  Zhang, Ning ^a   Weber, Aneil ^a   Li, Bonnie ^a   Lyons, Richard ^b   Contag, Pamela R ^a   Purchio, Anthony F ^a   West, David B ^a  

^a Xenogen Corporation   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; APIGENIN; DEXAMETHASONE; EBSELEN; EPIGALLOCATECHIN GALLATE; GAMMA INTERFERON; GENISTEIN; LIPOPOLYSACCHARIDE; LUCIFERASE; MESSENGER RNA; N TERT BUTYL ALPHA PHENYLNITRONE; NITRIC OXIDE SYNTHASE; PARACETAMOL; PENTOXIFYLLINE; PYRROLIDINE DITHIOCARBAMATE; RESVERATROL; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE INDUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SEPSIS; TRANSGENE; TRANSGENIC MOUSE;

EID: 0037604694     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.12.6307     Document Type: Article

References (51)

1. Nathan, C., and Q. W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915.
2. Vane, J. R., J. A. Mitchell, I. Appleton, A. Tomlinson, D. Bishop-Bailey, J. Croxtall, and D. A. Willoughby. 1994. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA 91:2046.
3. Kroncke, K. D., K. Fehsel, and V. Kolb-Bachofen. 1997. Nitric oxide: cytotoxicity versus cytoprotection: how, why, when and where? Nitric Oxide-Biol. Chem. 1:107.
4. Liao, W. 1996. Endotoxin: possible roles in initiation and development of atherosclerosis. J. Lab. Clin. Med. 128:452.
5. Lyons, C. R., G. J. Orloff, and J. M. Cunningham. 1992. Molecular cloning and functional expression of an inducible nitric oxide synthase from murine macrophage cell line. J. Biol. Chem. 267:6370.
6. Lorsbach, R. B., W. J. Murphy, C. J. Lowenstein, S. H. Snyder, and S. W. Russell. 1993. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing: molecular basis for the synergy between interferon-γ and lipopolysaccharide. J. Biol. Chem. 266:1908.
7. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051.
8. Salkowski, C. A., G. Detore, R. McNally, N. van Rooijen, and S. N. Vogel. 1997. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-γ, and TNF receptor-1-mediated signaling. J. Immunol. 158:905.
9. Szabo, C., C. Thiemermann, C. C. Wu, M. Perretti, and J. R. Vane. 1994. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc. Natl. Acad. Sci. USA 91:271.
10. Ross, R., and A. B. Reske-Kunz. 2001. The role of NO in contact hypersensitivity. Int. Immunopharm. 1:1469.
11. Calatayud, S., D. Barrachina, and J. V. Esplugues. 2001. Nitric oxide: relation to integrity, injury and healing of the gastric mucosa. Microsc. Res. Tech. 53:325.
12. Bolli, R. 2001. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J. Mol. Cell. Cardiol. 33:1897.
13. Weinberg, J. B. 1999. Nitric oxide and inflammation in autoimmune disorders. In Cellular and Molecular Biology of Nitric Oxide. J. D. Laskin and D. L. Laskin, eds. Marcel Dekker, New York, pp 199-224.
14. Kinugawa, K., T. Shimizu, A. Yao, O. Kohmoto, T. Serizawa, and T. Takahashi. 1997. Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. Circ. Res. 81:911.
15. Park, S. K., and S. Murphy. 1996. Nitric oxide synthase type II mRNA stability is translation- and transcription-dependent. J. Neurochem. 67:1766.
16. Contag, C. H., P. R. Contag, J. I. Mullins, S. D. Spilman, D. K. Stevenson, and D. A. Benaron. 1995. Photonic detection of bacterial pathogens in living hosts. Mol. Microbiol. 18:593.
17. Contag, P. R., I. N. Olomu, D. K. Stevenson, and C. H. Contag. 1998. Bioluminescent indicators in living mammals. Nat. Med. 4:245.
18. Zhang, W., J. Q. Feng, S. E. Harris, P. R. Contag, D. K. Stevenson, and C. H. Contag. 2001. Rapid in vivo functional analysis of transgenes in mice using whole body imaging of luciferase expression. Transgenic Res. 10:423.
19. Heinzel, F. P. 1990. The role of IFN-γ in the pathology of experimental endotoxemia. J. Immunol. 145:2920.
20. Buttery, L. D., T. J. Evans, D. R. Springall, A. Carpenter, J. Cohen, and J. M. Polak. 1994. Immunochemical localization of inducible nitric oxide synthase in endotoxin-treated rats. Lab. Invest. 71:755.
21. Khan, S. A., P. J. Strijbos, P. Everest, D. Moss, R. Stratford, P. Mastroeni, J. Allen, S. Servos, I. G. Charles, G. Dougan, and D. J. Maskell. 2001. Early responses to Salmonella typhimurium infection in mice occur at focal lesions in infected organs. Microb. Pathog. 30:29.
22. Hoffman, R. A., G. Zhang, N. C. Nussler, S. L. Gleixner, H. R. Ford, R. L. Simmons, and S. C. Watkins. 1997. Constitutive expression of inducible nitric oxide synthase in the mouse ileal mucosa. Am. J. Physiol. 272:G383.
23. Muriel, P. 2000. Regulation of nitric oxide synthesis in the liver. J. Appl. Toxicol. 20:189.
24. Milosevic, N., H. Schawalder, and P. Maier. 1999. Kupffer cell-mediated differential down-regulation of cytochrome P450 metabolism in rat hepatocytes. Eur. J. Pharmacol. 368:75.
25. Lowenstein, C. J., E. W. Alley, P. Raval, A. M. Snowman, S. H. Snyder, S. W. Russell, and W. J. Murphy. 1993. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90:9730.
26. Xie, Q. W., and C. Nathan. 1993. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharide. Trans. Assoc. Am. Physicians 106:1.
27. Weisz, A., L. Cicatiello, and H. Esumi. 1996. Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-γ, bacterial lipopolysaccharide and NG-monomethyl-L-arginine. Biochem. J. 316:209.
28. Murphy, W. J. 1999. Transcription regulation of genes encoding nitric oxide synthase. In Cellular and Molecular Biology of Nitric Oxide. J. D. Laskin and D. L. Laskin, eds. Marcel Dekker, New York, pp 1-56.
29. Zeisberger, E., and J. Roth. 1998. Tolerance to pyrogens. Ann. NY Acad. Sci. 856:116.
30. Hayashi, T., K. Yamada, T. Esaki, E. Muto, G. Chaudhuri, and A. Iguchi. 1998. Physiological concentrations of 17β-estradiol inhibit the synthesis of nitric oxide synthase in macrophages via a receptor-mediated system. J. Cardiovasc. Pharmacol. 31:292.
31. Friedl, R., M. Brunner, T. Moseslinger, and P. G. Spieckermann. 2000. Testosterone inhibits expression of inducible nitric oxide synthase in murine macrophages. Life Sci. 68:417.
32. Lin, Y. L., and J. K. Lin. 1997. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-κB. Mol. Pharmacol. 52:465.
33. Shimohashi, N., M. Nakamuta, K. Uchimura, R. Sugimoto, H. Iwamoto, M. Enjoji, and H. Nawata. 2000. Selenoorganic compound, ebselen, inhibits nitric oxide and tumor necrosis factor-α production by the modulation of jun-N-terminal kinase and the NF-κB signaling pathway in rat Kupffer cells. J. Cell. Biochem. 78:595.
34. Wendel, A., and G. Tiegs. 1986. A novel biologically active seleno-organic compound. VI. Protection by ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in mice. Biochem. Pharmacol. 35:2115.
35. De Vera, M. E., B. S. Taylor, Q. Wang, R. A. Shapiro, T. R. Billiar, and D. A. Geller. 1997. Dexamethasone suppresses iNOS gene expression by up-regulating I-κBα and inhibiting NF-κB. Am. J. Physiol. 273:G1290.
36. Walker, G., J. Pfeilschifter, and D. Kunz. 1997. Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-γ-stimulated RAW264.7 cells by dexamethasone: evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-transcriptional regulation. J. Biol. Chem. 272:16679.
37. Floyd, R. A. 1999. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 222:236.
38. Carney, J. M., P. E. Starke-Reed, C. N. Oliver, R. W. Landum, M. S. Cheng, J. F. Wu, and R. A. Floyd. 1991. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-α-phenylnitrone. Proc. Natl. Acad. Sci. USA 88:3633.
39. Edamatsu, R., A. Mori, and L. Packer. 1995. The spin-trap N-tert-α-phenylbutyinitrone prolongs the life span of the senescence accelerated mouse. Biochem. Biophys. Res. Commun. 211:847.
40. Folbergrova, J., Q. Zhao, K. Katsura, and B. K. Siesjo. 1995. N-tert-butyl-α-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia. Proc. Natl. Acad. Sci. USA 92:5057.
41. Miyajima, T., and Y. Kotake. 1997. Optimal time and dosage of phenyl N-tertbutyl nitrone (PBN) for the inhibition of nitric oxide synthase induction in mice. Free Radical Biol. Med. 22:463.
42. Liang, Y. C., Y. T. Huang, S. H. Tsai, S. Y. Lin-Shiau, C. F. Chen, and J. K. Lin. 1999. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20:1945.
43. Faure, V., C. Hecquet, Y. Courtois, and O. Goureau. 1999. Role of interferon regulatory factor-1 and mitogen-activated protein kinase pathways in the induction of nitric oxide synthase-2 in retinal pigmented epithelial cells. J. Biol. Chem. 274:4794.
44. Liu, S. F., X. Ye, and A. B. Malik. 1997. In vivo inhibition of nuclear factor-κB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J. Immunol. 159:3976.
45. Ryu, Y. S., J. H. Lee, J. H. Seok, J. H. Hong, Y. S. Lee, J. H. Lim, Y. M. Kim, and G. M. Hur. 2000. Acetaminophen inhibits iNOS gene expression in RAW264.7 macrophages: differential regulation of NF-κB by acetaminophen and salicylates. Biochem. Biophys. Res. Commun. 272:758.
46. Amin, A. R., P. Vyas, M. Attur, J. Leszczynska-Piziak, I. R. Patel, G. Weissmann, and S. B. Abramson. 1995. The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA 92:7926.
47. Wu, C. C., S. J. Chen, C. Szabo, C. Thiemermann, and J. R. Vane. 1995. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br. J. Pharmacol. 114:1666.
48. Stefanovic-Racic, M., K. Meyers, C. Meschter, J. W. Coffey, R. A. Hoffman, and C. H. Evans. 1994. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum. 37:1062.
49. Guillot, P. V., J. Guan, L. Liu, J. A. Kuivenhoven, R. D. Rosenberg, W. C. Sessa, and W. C. Aird. 1999. A vascular bed-specific pathway. J. Clin. Invest. 103:799.
50. Luth, H. J., M. Holzer, U. Gartner, M. Staufenbiel, and T. Arendt. 2001. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology. Brain Res. 913:57.
51. Sasaki, M., J. Yamaoka, and Y. Miyachi. 2000. The effect of ultraviolet B irradiation on nitric oxide synthase expression in murine keratinocytes. Exp. Dermatol. 9:417.